|
Volumn 73, Issue 6, 1994, Pages 639-644
|
Marker tumour response to Evans and Pasteur bacilie Calmette‐Guérin in multiple recurrent pTa/pT1 bladder tumours: report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)
a b c d e f |
Author keywords
BCG; marker tumour; Superficial bladder cancer
|
Indexed keywords
BCG VACCINE;
ADULT;
AGED;
ARTHRALGIA;
ARTICLE;
BLADDER CANCER;
CANCER RECURRENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DYSURIA;
FEMALE;
FEVER;
HEMATURIA;
HUMAN;
INTRAVESICAL DRUG ADMINISTRATION;
LIVER DYSFUNCTION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, INTRAVESICAL;
ADULT;
AGED;
AGED, 80 AND OVER;
BCG VACCINE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MYCOBACTERIUM BOVIS;
NEOPLASM RECURRENCE, LOCAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0028224759
PISSN: 00071331
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/j.1464-410X.1994.tb07548.x Document Type: Article |
Times cited : (34)
|
References (13)
|